TAG:
laboratory executive
Ten Myths of Lab Management That Led the Clinical Lab Industry Astray
By Robert Michel | From the Volume VI No. 11 – August 9, 1999 Issue
Part One of a Special Series CEO SUMMARY: One of our most popular series ever was the “13 Perilous Parallels” of laboratory management. This four-part story appeared in 1996 and chronicled similar management strategies used by various national laboratories during the…
“August 9, 1999 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VI No. 11 – August 9, 1999 Issue
Contrast the double digit premium increases demanded by HMOs for 1999 and 2000 with the recent Medicare announcement. Medicare will add 1.1% to hospital payments for overnight stays as this year’s inflation adjustment. With annual inflation under 2%, it certainly causes one to wonder what HMOs real…
McKesson on HBOC, PAML, Medicare Coding, Abbott Laboratories
By Robert Michel | From the Volume VI No. 10 – July 19, 1999 Issue
SCANDAL AT HBO & CO. TAINTS MCKESSON HBOC FIVE EXECUTIVES WERE SACKED by McKesson HBOC Inc.’s Board of Directors last month in response to allegations of financial improprieties. All five were employed by HBOC prior to its acquisition by McKesson last year. The termin…
Healtheon and WebMD Merger Portends Changes to Lab Testing
By Robert Michel | From the Volume VI No. 10 – July 19, 1999 Issue
SO FAR CLINICAL LAB EXECUTIVES have yet to see any profound changes that Internet-based services might cause to existing laboratory practices and procedures. That situation may change, however, with the merger of Healtheon Corporation of Santa Clara, California and WebMD, In…
Associated Pathologists Laboratories, Dynacare, Bio-Reference Labs, Quest, AmeriPath
By Robert Michel | From the Volume VI No. 9 – June 28, 1999 Issue
ASSOCIATED PATH LABS WINS PATENT FOR DRUGS OF ABUSE TEST IT’S NOT TOO OFTEN that independent commercial laboratories are awarded patents. Las Vegas-based Associated Pathologists Laboratories received a patent for a technique it developed relating to drugs of abuse testing….
Investors Coming Back To Clinical Lab Industry
By Robert Michel | From the Volume VI No. 8 – June 7, 1999 Issue
CEO SUMMARY: Wall Street money is beginning to flow back into the commercial laboratory industry. This time the beneficiary is Unilab Corporation of Tarzana, California. New York-based Kelso & Company signed an agreement to buy 93% of Unilab’s shares. The common perception among fin…
Palo Alto Needle Reuse Episode Widens in Scope
By Robert Michel | From the Volume VI No. 8 – June 7, 1999 Issue
CEO SUMMARY: As many as 15,000 people have been offered free blood testing because they may have been drawn by this phlebotomist since 1994. Regulatory action, private lawsuits, and media coverage are subjecting laboratories to unwelcome, even unwarranted, scrutiny. As the ramifications o…
Recognizing What the Marketplace Teaches Us
By R. Lewis Dark | From the Volume VI No. 7 – May 17, 1999 Issue
IT IS ONLY IN HINDSIGHT THAT MOST PEOPLE UNDERSTAND THE TRUTH of a situation. Unfortunately for laboratory employees in New York City, the lack of foresight by their leaders must inevitably lead to job cutbacks at three recently constructed laboratories. As you will read in our “Tale of Two Cities…
Diagnostics Companies React To Changing Lab Marketplace
By Robert Michel | From the Volume VI No. 7 – May 17, 1999 Issue
CEO SUMMARY: During the last five years, extensive consolidation among in vitro diagnostics (IVD) manufacturers has created a new class of industry giants. Their increased dominance of the IVD marketplace promises significant change to how laboratories acquire and use reagents, test kits,…
LabCorp Making Steady Progress On Path Back to Financial Health
By Robert Michel | From the Volume VI No. 7 – May 17, 1999 Issue
MOST OF THE LAB INDUSTRY is watching the impending acquisition by Quest Diagnostics Incorporated of SmithKline Beecham Clinical Laboratories (SBCL). This big news overshadows the steady gains made at Laboratory Corporation of America in its efforts …
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized